
Results from a small clinical trial suggest it may be possible to reduce the risk of dementia by eating during fewer hours of the day. The pilot study, which involved a weight-loss program for older women with overweight or obesity, showed modest cognitive improvements among those who limited their daily eating window instead of just reducing their calorie intake.
Scientists have introduced the world’s first chip capable of matching the operational speed of the human brain.
Researchers have developed a methodology that uses artificial intelligence to analyse the brain’s electrical activity during sleep, facilitating early diagnosis of Alzheimer’s. The study, published in the journal GeroScience, shows that analysing nocturnal brain waves through machine learning techniques allows for the identification of early neuronal alterations and the classification of patients into three distinct biological subgroups.
A new study demonstrates that whether an individual’s eyes are open or closed completely reverses the relationship between alpha band brain activity and mind wandering.
A study on human intracranial recordings shows that memory consolidation during sleep relies on coordinated activity among the orbitofrontal cortex, thalamus, and hippocampus. It provides direct evidence of how interactions between these regions affect memory performance, highlighting that synchronised neural signalling during sleep enhances memory retention.
New blood tests for early detection of Alzheimer’s disease offer a less invasive diagnostic alternative to brain scans and spinal taps, allowing for earlier identification and potentially more effective treatment options.
A recent study found that the human brain experiences significant changes in gene regulation and genome structure starting in midlife, particularly in the hippocampus. Researchers identified a notable shift in the brain’s immune system between ages 50 and 75, where embryonic-derived microglia decrease and are replaced by cells from peripheral blood with increased inflammation. These changes, along with a reduction in cells that maintain the blood-brain barrier, could explain why ageing is a key risk factor for neurodegenerative diseases like Alzheimer’s.
Scientists have shed new light on Alzheimer’s disease that could point to new directions for treatment.
Widespread evidence suggests that years of heading, tackling, and collisions in football and rugby may increase the risk of dementia and neurological diseases. A preliminary study presented at the Alzheimer’s Association International Conference in July 2026 examined 142 former professional footballers aged 30–60 alongside 56 individuals without a history of contact sports. While both groups performed similarly in cognitive tests, the retired footballers reported worse mood, higher anxiety levels, and poorer cognitive function.
A landmark study by scientists at King’s College London has identified new genetic risk factors for fibromyalgia syndrome, emphasising the nervous system’s role in the disorder’s development.
A pan-European study highlights key behavioural factors impacting health care professionals’ decisions to prescribe new treatments for neurodegenerative diseases. The findings emphasise the potential of behaviour change frameworks to enhance the adoption of these transformative therapies, addressing the rising global health care challenge posed by diseases like Parkinson’s. Understanding these prescribing influences is crucial for ensuring patient access to the best treatment options.
Analyzing UK sugar rationing data shows that limiting sugar exposure in utero and during the first two years of life reduces dementia risk by up to 23% and delays disease onset by 2.6 years
Researchers have developed an AI-powered speech neuroprosthesis that decodes high-density intracortical signals into fluent, high-fidelity synthetic speech. The dual-stage deep learning pipeline leverages a phonetic decoding layer paired with a large language model linguistic processor to achieve greater than 99% word accuracy with a processing latency of just 30 milliseconds.
A recent study showed that a three-week digital training program alongside standard drug treatment for Parkinson’s significantly improved patients’ motor function and brain motor circuits.
















































